SCHEMBL901495

SCHEMBL901495

CC#CCN(CCc1ccc(OC)c(OC)c1)C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.54
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2D6 P10635 1/20 0.51
BLM P54132 1/20 0.50
PMP22 Q01453 1/20 0.50
AOC3 Q16853 1/20 0.49
KDM4E B2RXH2 2/20 0.46
ALDH1A1 P00352 1/20 0.46
LDHA P00338 1/20 0.46
CDK8 P49336 1/20 0.46
CLK4 Q9HAZ1 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
CYP19A1 P11511 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4693129 0.79 CYP1A2 (0.54) L3MBTL1CYP1A2CYP3A4CYP2D6BLM
SCHEMBL4690968 0.78 KDM4E (0.55) L3MBTL1CYP1A2CYP3A4CYP2D6BLM
SCHEMBL5464541 0.74 ALDH1A1 (0.49) L3MBTL1CYP1A2CYP3A4CYP2D6BLM
SCHEMBL4094385 0.73 L3MBTL1 (0.50) L3MBTL1CYP1A2CYP3A4CYP2D6BLM
SCHEMBL2290451 0.73 CYP3A4 (0.56) L3MBTL1CYP1A2CYP3A4CYP2D6BLM
SCHEMBL7425880 0.73 CYP3A4 (0.52) L3MBTL1CYP1A2CYP3A4CYP2D6BLM
SCHEMBL10556236 0.71 MEN1 (0.55) L3MBTL1CYP1A2CYP3A4CYP2D6BLM
SCHEMBL2325918 0.71 L3MBTL1 (0.80) L3MBTL1CYP1A2CYP3A4CYP2D6BLM
SCHEMBL14276933 0.71 CYP3A4 (0.66) L3MBTL1CYP1A2CYP3A4CYP2D6BLM
SCHEMBL10338948 0.70 CYP3A4 (0.74) L3MBTL1CYP1A2CYP3A4CYP2D6BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012041934-A1 POLYSUBSTITUTED 2-AMINOIMIDAZOLES FOR CONTROLLING BIOFILMS AND PROCESS FOR THEIR PRODUCTION KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2012-04-05 WO disclosed